Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT00010036
Phase
PHASE2
Status
Completed

Conditions

  • Brain and Central Nervous System Tumors

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining carboplatin with irinotecan in treating patients who have glioblastoma multiforme.

Key Dates

Start date
May 31, 1999
Status verified
Mar 2011
Primary completion
Oct 31, 2001

Study Design

Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
NYU School of Medicine's Kaplan Comprehensive Cancer CenterNew YorkNew York10016-

Find similar trials in New York, NY

By research site
NYU School of Medicine's Kaplan Comprehensive Cancer Center· New York, NY

Related Studies